Most Favored Nation reference pricing is expected to compress U.S. WACs into a narrower corridor while pressuring ...

In 2024, the number of uninsured people in the United States rose for the first time since 2019, according to a recently ...

Pfizer announced in February 2025 that it was taking Beqvez (fidanacogene elaparvovec), its gene therapy for hemophilia B, ...

Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand. To prepare for his presentation at the ...

CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...

Patient adoption remains high. Data show that about 8.6 million patients used GLP-1 drugs for diabetes over a one-year period ...

The diagnostic criteria for narcolepsy type 1 have undergone some changes within the last few years, and it is important that ...

See how continuous glucose monitors replace painful finger sticks, deliver real-time alerts, and help prevent dangerous highs ...

World Experiences Switching Patients to CGM Devices,' the experts explore the following question: 1. What is a patient case ...

On the data side, tools now exist that integrate both medical and pharmacy claims into a holistic picture. An example is the ...

The first biosimilars referencing Humira became available in 2023. That year, 10 FDA-approved adalimumab are now on the ...

At the AMCP Annual Meeting, experts from Prime Therapeutics said education, policy alignment and collaboration can help ...